ARTICLE | Company News
Alkermes, Oklahoma negotiating value-based Medicaid purchasing agreements
August 31, 2018 6:07 PM UTC
The Oklahoma Health Care Authority (OHCA) said it has signed its first contract to negotiate value-based Medicaid purchasing agreements with Alkermes plc (NASDAQ:ALKS) for schizophrenia drug Aristada aripiprazole lauroxil.
OHCA is also close to agreements for an antibiotic and an epilepsy drug, both of which are undisclosed. The agency said it hopes to have one of the two contracts effective in September, but did not disclose details...
BCIQ Company Profiles